Trial Profile
A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2014
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary) ; Filgrastim
- Indications Febrile neutropenia
- Focus Registrational; Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 09 Apr 2014 New trial record